annb0t
Top 20
Bio-Rad Laboratories, Inc. BIO posted fourth-quarter 2024 adjusted earnings per share (EPS) of $2.90, which missed the Zacks Consensus Estimate of $2.93 by 1.0%. The bottom line decreased 6.4% from the prior-year quarterâs level.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The quarterâs adjustments primarily eliminate the impacts of certain non-recurring items, such as the amortization of purchased intangibles, restructuring costs and losses from the chang...
>>> Read more: BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The quarterâs adjustments primarily eliminate the impacts of certain non-recurring items, such as the amortization of purchased intangibles, restructuring costs and losses from the chang...
>>> Read more: BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket
